The global antimicrobial plastic market size is expected to reach USD 90.65 billion by 2033, registering a CAGR of 7.6% from 2026 to 2033, according to a new report by Grand View Research, Inc. The growing demand for products from packaging, health care, consumer products, and some other industries is expected to drive the market. Moreover, the growing complex epidemiological situations, such as COVID-19, microbial contamination, hospital-acquired infections, and healthcare-associated infections (HCAIs), are expected to fuel the growth of the market.
The healthcare segment has shown high penetration rates and it accounted for the majority of revenue share in 2021. This can be explained by the strong demand for antimicrobial plastics for the production of sterilized and infection-preventing products such as surgical cables, tubes, and orthopedic sutures. In addition, growing consumer health awareness, an increase in the elderly population in countries such as Japan, China, and the United States, and growing demand for high-quality medical equipment are expected to drive the market.
Companies in the market compete based on the quality of the products they offer and the technology used to produce antimicrobial plastics. Major players are engaging in mergers and acquisitions, expanding their manufacturing capacity, developing infrastructure, investing in R&D centers, and looking for vertical integration opportunities along the entire value chain. These initiatives help them meet growing global demand, stay competitive, improve sales and operations planning, develop innovative products and technologies, reduce manufacturing costs, and expand their customer base.
In February 2021, Sanitized AG introduced a new product to its existing BroadTect portfolio. This product provides protection to polymers against a wide range of microorganisms including gram-positive and gram-negative bacteria, mold and mildew, yeasts, and algae. It has higher temperature resistance and is suitable for thermoplastic processing methods such as extrusion and injection molding and thermoplastic polymers such as polyethylene (PE), polypropylene (PP), thermoplastic polyurethane (TPU), ethylene-vinyl acetate (EVA), polyvinyl chloride (PVC), and rubber.
Similarly, in March 2020, Covalon Technologies Ltd. formulated a new antimicrobial technology “CovaGuard” to kill coronavirus and other viruses and pathogens present on the surface of the polymers by using active antiviral and antimicrobial agents. This technology is capable of trapping, deactivating, and killing viruses over an extended period. This new technology will help in reducing the spread of coronavirus; protecting first responders, healthcare workers, and patients; and strengthening the company’s position in the healthcare industry.
Request a free sample copy or view report summary: Antimicrobial Plastic Market Report
Antimicrobial plastics are increasingly being used as a substitute for conventional materials in the healthcare sector for manufacturing medical instruments such as ventilators and anesthesia machines due to their pathogen-inhibiting properties
Growing consumer awareness about the health hazards posed by microbial contamination has been a pivotal driver for the antimicrobial plastics market
The global antimicrobial plastic industry is characterized by function-centric demand driven by health, hygiene, and contamination control across various end-use industries
Commodity plastic dominated the antimicrobial plastic market, accounting for a revenue share of 68.0% in 2025. The use of commodity plastic in applications such as consumer goods, packaging, food & beverage, and healthcare is expected to fuel market growth over the forecast period
Healthcare dominated the antimicrobial plastic industry, accounting for a 31.7% revenue share in 2025. Growth in the home healthcare sector is attributed to the lower costs associated with home care compared to hospital care.
Antimicrobial plastics are widely used in care homes, surgical rooms, hospitals, home care, and drop-in centers, with products including ceiling paints, floors, beds, handles, walls, case note holders, pull cords, cubicle curtains, and nurse call systems
Asia Pacific dominated the global antimicrobial plastic polymers market, accounting for the largest revenue share of 40.66% in 2025, attributable to the rapid expansion of healthcare infrastructure and urbanization.
Grand View Research has segmented the global antimicrobial plastic market report based on product, end use, and region:
Antimicrobial Plastic Product Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)
Commodity Plastics
Polyethylene (PE)
Polypropylene (PP)
Polyvinyl Chloride (PVC)
Polystyrene (PS)
Acrylonitrile Butadiene Systems (ABS)
Polyethylene Terephthalate (PET)
Engineering Plastics
Polyamide (PA)
Polycarbonate (PC)
Thermoplastic polyurethane (TPU)
Others
High-performance Plastics
Antimicrobial Plastic End Use Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)
Building & Construction
Automotive & Transportation
Healthcare
Packaging
Food & Beverage
Textile
Consumer Goods
Others
Antimicrobial Plastic Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Asia Pacific
China
India
Japan
Central & South America
Brazil
Argentina
Middle East & Africa
GCC Countries
South Africa
List of Key Players in Antimicrobial Plastic Market
BASF SE
Parx Materials N.V.
Ray Products Company Inc.
COVESTRO AG
King Plastic Corporation
Palram Industries Ltd.
Clariant AG
SANITIZED AG
RTP Company
Lonza
INEOS Styrolution Group GmbH
Milliken Chemical
BioCote Limited
Microban International
DuPont de Nemours, Inc.
"The quality of research they have done for us has been excellent..."